Nintedanib Dry Powder Inhalation
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Mannkind Corporation
Overview
Nintedanib Dry Powder Inhalation is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Nintedanib Dry Powder Inhalation clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nintedanib Dry Powder Inhalation for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.